Hypothermia treatment neuroprotects approximately 50% of neonates who present with moderate to severe hypoxic ischemic encephalopathy (HIE). N-acetylcysteine (NAC), a potent antioxidant, is neuroprotective in combination with hypothermia in neonatal hypoxia-ischemia (HI) female rats, but less protective in males. Vitamin D is a neurosteroid, which may provide immunomodulation and improve outcomes for both sexes.
Introduction
Neonatal hypoxic ischemic encephalopathy (HIE) is a devastating perinatal injury resulting in high mortality rates and lifetime difficulties for survivors with significant motor delays and cerebral palsy. Acute and chronic oxidative stress are important therapeutic targets in the treatment of HIE in the developing brain. Oxidative stress correlates with acute and subacute neural cell death in animal models, and may persist for weeks in the basal ganglia after moderate to severe HIE in human infants (Robertson et al., 1999) , portending a poor prognosis for neurodevelopmental outcomes (Shankaran et al., 2008; Azzopardi et al., 2009; Simbruner et al., 2010; Jacobs et al., 2013; Eicher et al., 2005) . Early institution of hypothermia, the standard of care, may be effective in decreasing oxidative stress and cell death in some, but not all cases of moderate to severe HIE. Half of near-term and term HIE neonates treated with hypothermia still have motor disabilities at 2 years of age, and cognitive disability (IQ < 85), with learning and memory problems at school age (Shankaran et al., 2008; Azzopardi et al., 2009; Simbruner et al., 2010; Jacobs et al., 2013) . To improve global outcomes for these neonates, our strategy has been to combine treatments that target early and chronic oxidative stress in a severe HI neonatal rat model that is unresponsive to hypothermia treatment.
In previous pre-clinical work we showed that short-term treatment with N-acetylcysteine (NAC) and hypothermia improved infarct volumes for female rats, but that male rats required long-term, systemic antioxidant treatment with NAC for functional improvement, perhaps due to prolonged oxidative stress (Nie et al., 2016) . NAC rapidly crosses the blood brain barrier and mitigates oxidative stress by directly scavenging oxygen free radicals and supplying cysteine, the rate-limiting substrate in synthesis of glutathione, a major intracellular antioxidant (Holmay et al., 2013; Katz et al., 2015) . With prolonged antioxidant support needed in male rats, we postulated that NAC would primarily decrease oxidative stress after severe HI, while an improved redox state would assist 1,25(OH) 2 D's modulation of chronic immune activation, providing neuroprotection for both sexes. Lipophilic 1,25(OH)2D readily crosses the blood brain barrier and provides rapid onset of action without need for activation in neurons and astrocytes (Fernandes de Abreu et al., 2009) . Acting through its nuclear receptor, 1,25(OH)2D is known to regulate the antiinflammatory immune response (Fernandes de Abreu et al., 2009) , increase neurotrophic factors after stroke (Balden et al., 2012) , and increase glutathione by inducing two rate-limiting enzymes in glutathione synthesis (Jain et al., 2014; Jain and Micinski, 2013) . In further support for use of 1,25(OH)2D, vitamin D deficiency is associated with worse outcomes in adults after stroke (Daumas et al., 2016; Park et al., 2015a; Turetsky et al., 2015) , and we identified vitamin D insufficiency in 70% of HIE infants in our randomized clinical trial, which was not improved by hypothermia (Lowe et al., 2017) . Therefore, we postulated that replenishing the active hormone, 1,25(OH) 2 D, might synergize with NAC and hypothermia to decrease oxidative stress acutely and lessen the transition to a chronic inflammatory state in neonatal rats, thereby improving functional outcomes after severe HI injury for both sexes.
Strong rationale supports active 1,25(OH) 2 D as a therapeutic target in severe HI refractory to hypothermia treatment. Vitamin D receptors are widely expressed in the CNS in rats, including the hippocampus (Eyles et al., 2005; Brewer et al., 2001; Langub et al., 2001) ; Both 25(OH)D and 1,25(OH) 2 D are actively degraded in presence of neuroinflammation in adult animal models (Balden et al., 2012; Paintlia et al., 2012) ; 1,25(OH) 2 D acts as a transcription factor by binding to its nuclear receptor, regulating expression of many proteins, including those involved in modulating microglial and T-cell immune responses and IGF I and other growth factor production, both of which may support recovery after stroke in adult animal models (Fernandes de Abreu et al., 2009; Eyles et al., 2007) ; vitamin D sufficiency is critically important for normal neurodevelopment (Groves et al., 2014; Cui et al., 2007) as well as outcomes after stroke in adult humans (Daumas et al., 2016) ; vitamin D treatment may be neuroprotective in rodent stroke models but is limited by hypercalcemia and weight loss at 1e2 mg/ kg in neonatal animals (Wang et al., 2000; Kajta et al., 2009) .
We hypothesized that administration of 1,25(OH) 2 D with NAC and hypothermia, would allow use of lower doses of 1,25(OH) 2 D, to promote immune regulation and growth factor production. We tested a two-week treatment of NAC and 1,25(OH) 2 D on long-term sensorimotor skills, behavior, and learning in male and female neonatal HI rats treated with hypothermia. We investigated endogenous vitamin D catabolism in the kidney and hippocampus and regulation of circulating cytokines 11 days post-HI during the transition from the sub-acute to the chronic phase of HI.
Methods

Animals
Postnatal day (PND) seven Sprague Dawley rats were used for all experiments (Harlan, Indianapolis, IN). Dams were purchased from Harlan (Indianapolis, IN) and arrived on postpartum day 3e5 and litters were pre-selected to contain 10 pups with an even distribution of males and females. Pups were housed with and fed by their dams until PND 21, when pups were weaned and separated from the dam and group housed according to sex. Animals were housed in the animal care facility of the Medical University of South Carolina and were kept in SPF facility at 22 C, 12/12 h light/dark cycle, and provided Harlan Teklad Diet 2918 and water ad libitum. All procedures were conducted during the light cycle in accordance with the Guide for the Care and Use of Laboratory Animals adopted by the National Institutes of Health and approved by the Medical University of South Carolina's Animal Care and Use Committee.
Animal reagents
Novaplus™ (Isoflurane, USP) (Abbot Laboratories, North Chicago, IL); N-Acetylcysteine (Acetadote, Cumberland Pharmaceuticals, Nashville, TN) and Calcitriol, 1, (Calcijex ® , Abbott Laboratories, North Chicago, IL) were used for both intraperitoneal (ip) and enteral (po) administration.
Hypoxia ischemia animal model
We used a modified Rice-Vannucci rat model to produce a severe HI insult, with unilateral ligation of the right common carotid artery under 1e2% isofluorance anesthesia, 2 h rest with dams, and 2 h exposure to 8% oxygen/92% nitrogen in an enclosed chamber, as previously described (Nie et al., 2016; Jatana et al., 2006; Vannucci et al., 2004) . After hypoxia, pups were subjected to 2 h hypothermia in a temperature controlled chamber in a 30 ± 0.5 C water bath, with free flowing gas of 21% oxygen. Sham operated animals underwent a neck incision with exploration and identification of right carotid artery under anesthesia, but without ligation or hypoxia. After 2 h recovery, sham animals were kept normothermic for 4 h in an open container in a 36.3 ± 0.5 C water bath in room air before returning to their dams. Sham animals received daily intraperitoneal (ip) injections of saline at the same time that hypothermia groups received either saline or NAC þ VitD. Rectal temperatures were monitored during the HI procedures in 11 rats that were not used for functional analyses. Mean rectal temperatures were 35.1 ± 0.5 C before and at the end of hypoxia, 30.6 ± 0.7 C during and at the end of hypothermia, and 34.2 ± 0.4 C 1 h after hypothermia in nest with dam. Litters were limited to 10 pups to ensure equal maternal access.
Study design, randomization, and power analyses
The translational investigations were designed to determine if a short, 2-week course of NAC þ VitD improved long-term cognitive and motor neuroprotection over hypothermia alone in a severe neonatal rat model of HI. Eighty-one PND 7 pups were randomized within litters to four groups: Sham (n ¼ 20); Hypothermia with saline (HYPO, n ¼ 21); Hypothermia þ NAC (HNAC, n ¼ 20); Hypothermia þ NAC þ 1,25(OH) 2 D (HNAC þ VitD, n ¼ 20). Sample size was stratified by sex for 10e11 rats per sex per treatment group. For translational studies, power analyses specified 9 rats per sex per treatment for 50% difference in hemispheric volume loss within sex (80% power, a ¼ 0.05), and a 20% difference in rope suspension at 7 weeks of life by Wilcoxon signed rank test (80% power, a ¼ 0.05) based on our previous behavioral data in hypothermia treated rat pups and another report using NAC pre-HI (Park et al., 2015b) .
1,25(OH) 2 D Dose Selection: In initial dose determination studies in combination with hypothermia and NAC 50 mg/kg/day, 1,25(OH) 2 D 1 mg/kg/day resulted in death of all pups. 1,25(OH) 2 D at 0.04e0.1 mg/kg/day improved infarct volumes and negative geotaxis, and 0.01 mg/kg/day had no effect (data not shown). We chose the highest dose (0.1 mg/kg/day) that showed efficacy without toxicity for these studies.
Route of administration: In clinical practice HIE neonates typically take enteral feeds during the second week and may not have intravenous access, or may need to take medications orally after discharge, at an average of 10 days of age. To enhance translational potential of this neuroprotection protocol, NAC 50 mg/kg/day was administered with 1,25(OH) 2 D 0.1 mg/kg/day or saline ip, starting 1 h after initiation of hypothermia, and continued daily by ip injection on PND 8e14, then by gavage (po) on PND 15e21. Euthanasia was on PND 49 (6 weeks post HI).
In the second set of experiments involving biochemical studies, we used the same treatment groups, doses and administration routes for 11 days treatment with sacrifice on PND 18. We chose day 18, as male rats in HYPO and HNAC groups show loss of function on rope suspension (PND 17e21, Fig. 3cef ), and 1,25(OH) 2 D might prevent conversion to a chronic neuroinflammatory state after HI injury (Becker et al., 2005) . Animals were randomized to sham (n ¼ 11); HYPO (n ¼ 16), HNAC (n ¼ 17) or HNAC þ VitD (n ¼ 18) with sexes balanced within treatment groups as closely as possible. Power analysis required a minimum of n ¼ 8 per sex per treatment group to detect a difference compared with hypothermia alone group, based on our previous biochemical data at 24e48 h by Wilcoxon signed rank test (80% power, a ¼ 0.05) and other reports of changes in serum 25(OH)D and growth factors (Balden et al., 2012) .
Neurobehavioral reflexes, coordination and learning testing
Specific protocols were followed in the same order of testing each day for each litter by examiners blinded to treatment group (Fig. 1 ). For long term neurobehavioral studies, reflexes were performed daily from PND 8e21 including eye opening, fore-and hindlimb placing and grasp, righting reflex, and negative geotaxis test of orientation-righting combined with locomotion to top of board within a time limit of 30 s, as previously described (Nie et al., 2016; Lubics et al., 2005) . From PND 14e49 functional tests of strength (1 and 2 arm rope suspension), use of affected paw (cylinder rearing test), sensorimotor coordination (rotarod), and anxiety and exploration behaviors (open field test) were performed in that order twice per week on the same day. From PND 35e49 daily tests for fine motor skills (staircase pellet retrieval) and learning and memory (4 trials/day, one watermaze paradigm tested each day), were performed as detailed (Fig. 1) . For advanced sensorimotor integration, sticky dot removal was tested on PND 45e50 (5 trials/day).
Cylinder rearing test
To measure usage of the unaffected vs. the affected paw, animals were videotaped exploring a four liter clear beaker for two minutes twice a week for a total of ten tests. The number of times the animal touched the wall with the unaffected, affected, or both paws was recorded, and an asymmetry score was calculated with the following formula: 100 Â (unaffectedaffected)÷(unaffected þ affected þ both paws) (Brooks and Dunnett, 2009 ). Performance over the study period was compared using mixed model analysis.
Two and one-arm rope suspension
Strength and endurance was tested using 1 and 2 arm rope suspension as previously described (Nie et al., 2016; Jatana et al., 2006) . For two-arm suspension rats were suspended by both forelimbs on a 1/6 00 diameter nylon rope above a foam pad. The duration of suspension time until the rat landed on the foam pad or climbed to the post-end (latency) was measured up to maximum time of 30sec. After testing two-arm suspension, rats had a 10 min rest before the one-arm suspension test, in which the unaffected limb was immobilized with tape and the rat was required to use the contralateral, affected limb for suspension. The average of 3 daily trials was used in analysis.
Adhesive removal test (sticky dot)
An adhesive dot label was placed on medial aspect in the palm of alternating paws, then both paws were touched simultaneously. The total time required for the rat to recognize and attend to the sticker with shaking or bringing it to mouth and to remove the sticker up to a maximum of 300 s were averaged for each paw, 5 trials per day (Bouet et al, 2009 (Bouet et al, , 2010 Freret et al., 2006) . Performance over the 5 days of testing between treatment groups was compared by mixed model analysis.
Staircase pellet retrieval
Skilled reaching was tested on the staircase apparatus. One quarter of circular piece of fruit-flavored cereal was placed on each step in a color-coded paradigm (Fig. 4c) . Color-coding the steps permitted weighting results by difficulty (top step ¼ 1, second step ¼ 2, etc.), as lower steps required more skill for reaching and grasping the pellet. The number and color of cereal pieces eaten (successes right/left) or displaced (attempted right/left) in 10 min was recorded.
Rotarod test
We recorded the time rats walked on a rotating rotarod at a constant velocity of 13 rpm (PND 21, 24, 28, 31, 35) , and on a more challenging accelerating rotarod, with increasing velocity from 13 to 47 rpm (2 rpm every 10 s; PND 38, 42, 45 49), without falling off, up to 180 s maximum time. The average of 3 trials per day was analyzed.
Open field testing
Animals were observed for 5 min after being placed in the center of a circular (diameter 43 cm) or square open-field (60 Â 60 cm). Each field was tested once per week, from PND 14e31 for behavioral responses to stress (grooming behavior and number of defecation boluses). Distance traveled, average velocity, and time against corners or walls was recorded using SMART Video Tracking System (Panlab/Harvard Apparatus, Holliston, MA).
Morris water maze
Water maze testing is a well-validated measure of spatial navigation, reference memory, and hippocampal-dependent learning and synaptic plasticity (Vorhees and Williams, 2006; Arteni et al., 2003) . A series of water maze tests were conducted sequentially (cued learning, spatial acquisition/place learning, reference memory, and working memory), to evaluate short and long term learning retention, learning strategies, and working memory (Lubics et al., 2005; Vorhees and Williams, 2006; Arteni et al., 2003; Ikeda et al., 2006) . For all testing paradigms, rats were placed in a 6 ft diameter pool with opaque water at 22 C, with external cues on the walls in each quadrant. Animals that were unable to locate the 10 Â 10 cm platform for exit from the pool were directed to its location at the end of 1 min and given 10 s on the platform before removal from the maze. The time to find the platform (latency), swimming speed, path length, and swim pattern was recorded.
2.5.7.1. Cued learning with a visible platform. Animals were placed on a visible platform 2 cm above the water surface for 20 s to foster learning of external location cues for water maze navigation. Rats were then started from a different quadrant for each of 4 daily trials, with the platform in the same position, and 10 min rest between trials (PND 35e37).
2.5.7.2. Spatial acquisition/place learning with invisible platform. For spatial learning tests on PND 38e42, the platform was submerged 2 cm below water line, in the same location for all days. Animals were released in alternating quadrants opposite the platform in 4 daily trials and had to match their position with external visual cues to find the invisible platform. In this paradigm, the rat's long-term memory of platform position can be used to reduce time to find the platform within the day and from day to day over the 5 days of testing.
2.5.7.3. Reference memory. A single probe trial was performed on PND 43, after the invisible platform trials. The platform was removed from the water maze, and one trial of 60 s was performed to record recognition of a cm circumference around the platform. Increasing time spent swimming further from the platform position indicates less reference memory retention, as does a more random swim pattern with less direct route to the platform radius.
2.5.7.4. Working memory. We tested working memory as the final learning task on PND 44e48. The platform was submerged in a new place each day, in the same position for all animals for that day. Rats were released from different positions for each of the 4 daily trials (Fig. 7a) . In the first trial each day, the rat finds the novel platform by chance and/or searching strategy. In trials 2e4 of each day, the rat must use working memory to match each novel starting position to the fixed platform place, without the benefit of long-term reference memory (Vorhees and Williams, 2006) . Trial latency times were averaged across 5 days of testing.
Gross brain pathology at sacrifice
After long-term functional outcomes studies, rats were sacrificed on PND 49 under pentobarbital anesthesia, and brains removed and photographed, then frozen in OCT for future studies. For assessment of brain atrophy, we used an expedient Gross Brain Pathology (GBP) score similar to scoring systems used and validated by others (Brooks and Dunnett, 2009 ). Coronal and lateral images of the brains (Fig. 2a) were prepared by a separate research assistant, not involved in randomization or treatment, and degree of atrophy was scored by three independent analysts blinded to treatment group, according to the following scale: (1) symmetric hemispheres; (1.5) slight asymmetry; (2) cyst or atrophy reducing the ipsilateral hemisphere up to 33% of contralateral hemisphere; (3) cyst or atrophy reducing the ipsilateral hemisphere by 33e66% of the contralateral hemisphere; (4) cyst or atrophy reducing the ipsilateral hemisphere by 66%e100% of the contralateral hemisphere (Hobbs et al., 2008; Seo et al., 2013; Sabir et al., 2012; Liu et al., 2012; Thoresen et al., 1996) . Inter-rater reliability was 96%. To validate our scoring system within this group of rats, we analyzed performance on five functional outcomes over PND 14e49 (two and one-arm rope suspension, negative geotaxis, adhesive removal test, and skilled reaching test) by GBP score in rats from all experimental groups including sham (n ¼ 81). Excellent stratification of function was delineated by the range of GBP scores (one-arm rope suspension illustrated in Fig. 2b ; Supplemental  Fig. 1aed) . GBP scores were then dichotomized to severe (GBP scores 3e4) or mild to moderate (GBP scores 1e2), similar to outcomes in clinical HIE trials.
Serum and tissue samples for PCR, western blot, vitamin D assay
At sacrifice on PND 18, under pentobarbital anesthesia rats were exsanguinated by cardiac puncture followed by decapitation. Brain was rapidly dissected out, and frozen on dry ice in OCT. Kidney tissue was flash frozen, and serum was separated by centrifugation. All tissues and serum were stored at À80 C. Ipsilateral and contralateral hemispheric areas were measured at the anterior hippocampus by Image J (http://imagej.nih.gov/ij/). Hippocampal and cortical tissue were dissected at this location. Ipsilateral cortex was severely damaged after HI in many animals, and hippocampal structures were also reduced or missing even in some GBP 2 specimens. By necessity, these studies excluded animals with severe GBP scores or those with severely damaged tissue.
CYP24A1, the enzyme responsible for hydroxylation (degradation) of bioactive VitD, was assessed by mRNA expression in PND 11 homogenized kidney tissue by real-time PCR and normalized to GAPDH (SYBR green PCR, Bio-Rad) using the following protocol: activation of iTaq DNA polymerase at 95 C for 10 min, followed by 40 cycles of amplification at 95 C for 30 s and 63 C for 1 min; and the following primers: CYP24A1 FP: 5 0 -TTA-GACCCGAACGCTGGCTTGAAA-3'; RP: 5 0 -AGCAAA-GAGCCAAGTGGAGCTGTA-3' (Integrated DNA Technologies, Inc., Coralville, IA) (Lubics et al., 2005) . 25(OH)D levels were measured in serum samples collected at sacrifice on PND 18, using a rapid, direct radioimmunoassay previously described (Bouet et al., 2009; Balkaya et al., 2013) . Hippocampal and cortical tissue samples were homogenized in ice-cold 2% SDS buffer and analyzed by Western blot analysis for CYP24A1 (Santa Cruz SC66851), iNOS (SC7271), and b-actin. Band intensities on autoradiographs were quantified by Image J and ratios of individual pups were averaged for group analyses.
Cytokine multiplex assay
Serum samples were measured in duplicate on a BioPlex platform as previously described (Rat chemokine/cytokine magnetic bead panel, RCYTOMAG-80K, Millipore) (Jenkins et al., 2012) . G-CSF, Eotaxin, GM-CSF, IL-1a, Leptin, MIP-1a, IL-4, IL-1b, IL-2, IL-6, IL-13, IL-10, IL-12p70, IFNg, IL-5, IL-17A, IL-18, MCP-1, IP-10, GRO, VEGF, TNFa, and RANTES concentrations were based on the better logistic fit using either 4 or 5 parameters and a 7 point standard curve.
Statistical analysis
Data are expressed as mean ± SEM and assessed by parametric or nonparametric one-way ANOVA with Tukey post-hoc or mixed modeling, where applicable. Generalized linear mixed modeling with fixed effects was used for repeated measures over time in learning and performance tasks. The level of significance considered for all statistical analysis was p < 0.05. Error bars represent standard error of the mean in all figures. All statistical calculations were performed using SPSS version 20.0.
Results
3.1. HNAC þ VitD treatment significantly decreased the incidence of severe gross brain pathology HNAC þ VitD therapy significantly reduced the number animals with severe GBP scores compared to both HNAC and HYPO groups, with 50% improvement over HYPO alone (Fig. 2c) . In males, HNAC þ VitD followed the same pattern, while females had did not have improvements with HNAC þ VitD over HNAC alone (Fig. 2d) .
HNAC þ VitD treatment improved motor skills compared with hypothermia alone
The cylinder rearing test asymmetry score measures the number of times the affected paw versus unaffected paw was used to explore the cylinder rearing (Fig. 3a) , and was significantly different among treatment groups (F ¼ 17.5, p < 0.001) and sex (F ¼ 6.7, p ¼ 0.01). Sham showed less paw asymmetry than all HI groups (p < 0.002). HNAC þ VitD rats had significantly less paw asymmetry than HYPO and HNAC (p ¼ 0.001). By sex, males exhibited significantly more paw asymmetry than females particularly within the HYPO group (Fig. 3b) .
Rope suspension testing measures both compensatory (twoarm) and affected limb (one-arm) strength and is significantly different among treatment groups (F > 25.5, p < 0.001) and sex (F > 22.1, p < 0.001) with a significant interaction (F > 3.0, p < 0.049). Rats in the HNAC þ VitD group held on to the rope significantly longer over time than HYPO and HNAC in both twoarm (Fig. 3c , p < 0.001) and one-arm tests (Fig. 3e, p < 0.001) . Males performed significantly worse than females in HYPO as well as HNAC groups in both two-arm (Fig. 3d ) and one-arm (Fig. 3f) rope suspension tests. A drop-off in performance was observed beginning on day 17e21, in HYPO and HNAC males, while HNAC þ VitD males continued to improve. This corresponds to the same time in which weights became significantly different by sex (PND 21, p 0.034, data not shown). In two-arm rope suspension, HNAC þ VitD improved male performance throughout the study, equal to females. In one-arm rope suspension, males showed declining performance after day 35, demonstrating the limit of unilateral arm strength as male animals gained more weight.
HNAC þ VitD treatment partially mitigates deficits in fine motor skills
The adhesive removal test was significantly affected by treatment in both the affected (F ¼ 4.43, p ¼ 0.004, Fig. 4a ) and unaffected (F ¼ 2.93, p ¼ 0.034, Fig. 4b ) paws, but not sex over the 5 days of testing. Significant deficits were observed in the affected paw for both HYPO and HNAC compared to sham with similar tends in the unaffected paw. HNAC þ VitD rats were faster removing the sticky dot than HYPO and HNAC rats in both paws and had performance similar to sham.
Staircase pellet retrieval tests forearm reaching and fine motor grasping to successfully retrieve and eat pellets. With poor fine motor skills, the rat will rake the pellet, dislodging it, but not removing it from the staircase. Treatment effects were observed in both limbs (F ¼ 38.2, p < 0.001), with an interaction of sex in affected limb (F ¼ 3.1, p ¼ 0.028). All HI animals exhibited poor performance in this fine motor task compared to Sham in both limbs (all p < 0.001). In the affected limb (Fig. 4e) , all HI females performed similarly. However, HYPO males performed worse than females, with very little success over the testing period. HNAC þ VitD males had improved performance vs. HYPO males, similar to female HNAC þ VitD performance. In the unaffected limb (Fig. 4f) , HNAC þ VitD improved performance over both HYPO and HNAC, without any effects of sex. 
HNAC þ VitD treatment improves sensorimotor adaptation after HI, particularly in male rats
In the rotarod protocols, sensorimotor adaptation to constant and accelerating velocity was measured by time walking on the rotating rod, and showed significant effects of treatment (F ¼ 4.3, p ¼ 0.006) and sex (F ¼ 11.6, p ¼ 0.001), with a trend towards a sex and treatment interaction in the accelerating rotarod only (F ¼ 2.4, p ¼ 0.068). In both the constant and accelerating rotarod tests, Sham and HNAC þ VitD performed significantly better than HYPO and HNAC groups (Fig. 5a and c) , with females staying on the rod consistently longer than males ( Fig. 5b and d) . With the more difficult acceleration protocol, Sham and HNAC þ VitD groups showed rapid sensorimotor adaptation, and stayed on the rotarod progressively longer over time, while HYPO and HNAC groups did not improve (Fig. 5c) . Addition of 1,25(OH) 2 D to HNAC substantially improved performance of male animals compared to HYPO and HNAC alone (Fig. 5d) , which persisted to day 49. HNAC þ VitD group performance was equivalent to Sham group over time.
HNAC þ VitD treatment groups demonstrate less anxiety
When placed in the stressful environment of the open field, time spent near the wall or corners (thigmotaxis), and grooming can be markers of anxiety. The circular open field is the more threatening of the two, as the square open field offers corners for hiding and protection for rats. In the circular open field, HNAC þ VitD animals entered the wall area significantly less often than HYPO (p ¼ 0.008) and HNAC animals (p ¼ 0.018) over all days, indicating less anxiety and need to seek shelter (Fig. 6a) . In the square open field, HI rats had less overall movement into the open area, with no difference between groups (Fig. 6b) . HNAC þ VitD rats groomed significantly more than HYPO (p ¼ 0.002) and HNAC (p ¼ 0.026) on PND 14, but over time acclimated better with significantly less grooming than HYPO on PND 28 (p ¼ 0.045, Fig. 6c ). No sex differences were observed in the open field testing.
HNAC þ VitD treatment improved intra-day cued learning
For cued learning in the watermaze, the visible platform was maintained in same position for the 4 trials per day over 3 days of testing, but rats were started from different positions for each trial. There were significant effects of treatment, day and trial (F ¼ 16.7, all p < 0.001), without sex effects. All treatment groups improved their latency time to locate the fixed platform with visual cues over the 3 days of testing (Fig. 7a) , and exhibited long-term memory of the visual cues overnight, with no difference in latency between trial 1 of a day and trial 4 of the previous day. While Sham performed significantly better than all HI groups, latency times for HNAC þ VitD animals were significantly shorter than HYPO and HNAC rats over the 3 days of testing (Fig. 7a) . Hypothermia treatment groups did not plateau, as sham animals did, suggesting they did not reach maximal performance within the 3 days of testing. Swim speed was not significantly different between the treatment groups and path length (distance traveled to the locate the platform) agreed with the latency data (not shown).
HNAC þ VitD improved intraday spatial learning
Spatial reference testing using the invisible platform evaluates the animal's ability to use internal watermaze visual clues to learn the location of an underwater platform and then develop strategies to find it when entering the pool from a different location. A mixed model showed significant effects of treatment, trial, sex and day (F ¼ 9.1, all p ¼ 0.003), and an interaction of sex and day (Fig. 7c , F ¼ 4.3, p ¼ 0.0002), indicating males and females learned the task differently. Males were significantly worse on later testing days, irrespective of treatment group. There was a trend towards an interaction between treatment and trial (F ¼ 1.9, p ¼ 0.053).
While all HI groups underperformed compared with sham, HNAC and HNAC þ VitD rats were significantly faster than HYPO in the combined sex analyses over the 5 days (Fig. 7b) . Only HNAC þ VitD and Sham exhibited intraday learning, reducing their time to locate the platform from trial 1 to 4 within a day (p < 0.05, 4 out of 5 days). The HYPO and HNAC groups had no significant intraday learning other than HYPO on day 1.
Swim speed and path length may affect latency to the platform. Swim speed showed significant effects of treatment, sex, and trial (F ¼ 3.5, p < 0.015) with a sex and treatment interaction (F ¼ 3.0, p ¼ 0.030, Fig. 7d ). HNAC þ VitD animals swam significantly faster than other groups (p < 0.001), particularly evident in males (p < 0.001). Path length also showed significant effects of treatment, sex, day and trial (F ¼ 8.6, p < 0.001) and a trend towards a sex and treatment interaction (p ¼ 0.055) (Fig. 7e) . The HNAC þ VitD group swam the fastest over less total distance before reaching the platform (Fig. 7d and e) , resulting in the overall improved performance over HYPO. Thus, these animals were able to search the watermaze at a faster pace and learn more quickly, thereby reducing their overall time in the maze.
Long-term memory was not different between groups
After 5 days of learning the hidden platform location, probe testing was performed with the platform removed to test longterm memory on day of life 43 (Fig. 8a) . There was a significant effect of treatment (F ¼ 3.0, p ¼ 0.036) with no sex effect or interaction. HNAC and HNAC þ VitD were equivalent to Sham in total time spent in the target area.
NAC treatment improved working memory
For working memory testing, the invisible platform location varied each day (Fig. 8b) , challenging the animal to develop search strategies and use spatial references during the intraday trials to improve latency. Treatment, day, and trial number had significant effects (F ¼ 2.9, p ¼ 0.023) on time to reach the platform, with a significant interaction effect of treatment and trial (F ¼ 2.6, p ¼ 0.006, Fig. 8c ), but without sex effect. Latencies were the similar in the HI groups in the first trial of each day, as expected with novel platform positions. Compared with HYPO rats, HNAC and HNAC þ VitD rats were significantly faster at finding the novel platform particularly on trial two, but did not continue to improve to trial 4 (Fig. 8c) . Task failure percentage (Fig. 8d) was also significantly affected by treatment, day, and trial (F ¼ 2.5, p ¼ 0.037) with an interaction of treatment and trial (F ¼ 2.5, p ¼ 0.008). HYPO rats failed to locate the platform significantly more often than HNAC þ VitD in all four trials.
Taken together these studies indicate that severe brain atrophy was reduced and long-term global performance was improved on multiple strength, sensorimotor integration, spatial learning and working memory tasks after 2 -week treatment with NAC and 1,25-OH 2 D, compared with rats treated with hypothermia alone after severe HI injury.
Vitamin D catabolism in the second week after HI
In a second set of experiments, neonatal rats were treated with same HI hypothermia protocol, but sacrificed 11 days post HI (PND 18), to investigate vitamin D inactivation by mitochondrial enzyme CYP24A1 hydroxylase during the transition to chronic neuroinflammation. Our lab and others have reported CYP24A1 catabolism of 25(OH)D and 1,25(OH) 2 D is upregulated in adult neuroinflammatory models and may account for the observed improved outcomes with 1,25(OH) 2 D treatment (Balden et al., 2012; Paintlia et al., 2015) .
3.11. Vitamin D catabolic enzyme CYP24A1 was upregulated after HI in hippocampus, but not kidney HI injury increased CYP24A1 protein levels in the ipsilateral versus the contralateral hippocampus in all treatment groups (Fig. 9a,b) , but not in the cortex, confirming that hippocampal vitamin D degradation persists at least 11 days in after severe HI. iNOS protein levels were positively correlated with CYP24A1 protein in the ipsilateral hippocampus (r ¼ 0.598, p ¼ 0.003, n ¼ 22, Fig. 9c) and cortex (r ¼ 0.486, p ¼ 0.016, Fig. 9d ) regardless of sex or treatment. CYP24A1 protein in the ipsilateral hippocampus also negatively correlated with the ipsilateral hippocampal volume loss expressed as ratio of ipsilateral to contralateral hemispheric volume (r ¼ À0.488, p ¼ 0.016, n ¼ 24). Taken together, these data suggest that vitamin D degradation via CYP24A1 expression is upregulated by HI in hippocampus, and significantly relates to hippocampal volume loss and iNOS expression as marker of ongoing neuroinflammation.
CYP24A1 increased in both hippocampi after HNAC þ VitD treatment in females. This is consistent with intact (negative) feedback regulation as higher levels of vitamin D regulate its own degradation (Fig. 9a,b) . However, in males, CYP24A1 protein levels decreased after treatment with HNAC þ VitD in the ipsilateral hippocampus, and did not change in the contralateral hippocampus, consistent with dysregulation of normal feedback of 1,25(OH) 2 D on CYP24A1 in both hippocampi (not shown).
We next examined renal expression of CYP24A1, which regulates circulating 25(OH)D and 1,25(OH) 2 D concentrations. HYPO and HNAC animals had lower renal CYP24A1 protein concentrations at 11 days vs sham (Fig. 7c ), but HYPO also had lower 25(OH)D serum concentrations (Fig. 7d) . Renal CYP24A1 was markedly higher after 1,25(OH) 2 D treatment, and serum 25(OH)D levels were lower, suggesting intact renal feedback regulation of circulating 25(OH)D and 1,25(OH) 2 D in the second week after HI in Fig. 9 . Hippocampal CYP24 protein levels in each hemisphere by treatment at 11 days after HI (a,b); iNOS versus CYP24A1 protein in ipsilateral hippocampus and cortex (c,d); Renal CYP24 fold expression by treatment (e); Serum 25(OH)D levels by treatment (f). (a) The ipsilateral hippocampal CYP24 levels were elevated in HYPO males compared to HNAC þ VitD (*p < 0.029), but not in the contralateral hemisphere (b). In the contralateral hemisphere, female HNAC þ VitD animals had increased CYP24 protein (*p ¼ 0.03), indicating intact feedback regulation, which was not observed in males, and a possible sex-specific response to 1,25(OH) 2 D administration. hypothermia treated animals.
iNOS protein concentrations were significantly correlated with CYP24A1 protein in the ipsilateral hippocampus (c) and cortex (d), without a sex or treatment difference at this time point. (e) Renal CYP24 expression was reduced in HYPO and HNAC treated animals vs. control (#p < 0.002), and no sex differences were observed. (f) Circulating 25(OH)D levels were significantly lower in male HYPO compared to Sham and HNAC (#p < 0.037), which was not observed in females. HNAC þ VitD resulted in lower serum 25(OH)D levels and higher renal CYP24 expression compared to all other groups (e,f,*p < 0.001), consistent with negative feedback inhibition.
3.12. Serum inflammatory markers are associated with 25(OH)D, but were not different by treatment group or sex
We studied serum inflammatory markers at 11 days after HI to detect a potential transition to a chronic immune activation state after HI in animals. Higher MCP-1/CCL2 (rho ¼ À0.627, p < 0.001), IL-18 (rho ¼ À0.443, p ¼ 0.004), and RANTES (rho ¼ À0.498, p ¼ 0.001) all correlated with lower serum 25(OH)D concentrations at sacrifice. Serum levels of MCP-1, IL-18, and RANTES also correlated with each other, (rho> 0.398, p ¼ 0.009) suggesting joint activation of monocytes, microglia and T-cells, respectively (Jain and Micinski, 2013; Fukui et al., 2006) . However, CCL2, IL-18 and RANTES did not differ by sex or treatment.
Serum leptin levels decreased in severe injury and normalized with HNAC þ VitD
Among serum growth factors regulated by 1,25(OH) 2 D that have been shown to be neuroprotective after stroke, circulating leptin was significantly reduced in animals with severe compared to mild/ moderate GBP (Fig. 10a) (Zhang et al., 2013) . Circulating leptin positively correlated with serum 25(OH)D in HYPO and HNAC groups, without differences by sex (rho ¼ 0.516, p ¼ 0.028). 1,25(OH) 2 D treatment restored leptin levels in the severe GBP group similar to Sham (Fig. 10b) .
Discussion
In our and others' animal models of neonatal HI, impairment in sensorimotor, anxiety, attention-deficit and memory tests are readily demonstrated (Bouet et al., 2010; Miguel et al., 2015) and show a male disadvantage (Bona et al., 1998; Smith et al, 2014 Smith et al, , 2015 Waddell and McCarthy, 2012; Tsuji et al., 2010) , which is not ameliorated by hypothermia treatment in severe models (Sabir et al., 2012) . Our current studies show that a unique combination of active 1,25(OH) 2 D and NAC provides robust, long-term neuroprotection in nearly all functional tests of motor and integrated sensorimotor skills, as well as in anxiety and memory in both sexes, compared with rats treated with hypothermia alone in our severe neonatal rat model of HIE. In evaluating outcomes for differences between sexes, females seemed to benefit from the addition of NAC to hypothermia in strength (rope suspension) and fine motor skills (staircase), and incrementally by the addition of 1,25(OH) 2 D in paw use and sensorimotor adaptation (accelerating rotarod). However, the improvement in performance among neonatal male rats by the addition of 1,25(OH) 2 D to NAC and hypothermia was striking. Male rats treated with two weeks of low dose 1,25(OH) 2 D and NAC improved significantly in strength, sensorimotor adaptation, longterm memory (watermaze probe trial), and anxiety (open field).
This is the first report to investigate Vitamin D metabolism in neonatal HI model and the administration of 1,25(OH) 2 D in a therapeutic combination in neonatal HI injury. We discovered that HI increases the vitamin D catabolic enzyme CYP24A1 in the CNS, as shown in adult rodents 5 days after stroke (Balden et al., 2012) , substantiating the hypothesis that HI increases vitamin D degradation at 11 days in neonatal HI animals. We also found that circulating prohormone 25(OH)D is chronically depleted 11 days after severe HI, as we have shown acutely on days 1e3 in our human HIE data (Lowe et al., 2017) , potentially limiting endogenous CNS restoration of active hormone 1,25(OH)2D. Hypothermia treatment alone neither rescues serum 25(OH)D deficiency nor reverses the increased degradation of vitamin D in the CNS after severe HI.
Neuroinflammation, as measured by iNOS in both hippocampus and cortex, is positively related to the deactivation of vitamin D regardless of sex in our study, just as in adult male and female HI models (Balden et al., 2012; Paintlia et al., 2012 Paintlia et al., , 2015 . Systemic inflammation, as measured by circulating cytokines, is also inversely related to serum vitamin D levels, including MCP-1 from circulating immune cells regulated by vitamin D (Jain and Micinski, 2013; Garcion et al., 1998) . Our data adds novel findings in sex difference, in that hypothermic males have a greater serum 25(OH) D deficiency and higher CNS CYP24A1 after HI than hypothermic females, and that 1,25(OH)2D feedback regulation of CYP24A1 is impaired in male brains for a prolonged period after HI, but not in females. This implies that neonatal male rats have a different 1,25(OH)2D transcriptional activation threshold than female rats after HI, the nature of which has yet to be determined in adult or neonatal HI.
Replenishing active 1,25(OH) 2 D hormone has been shown to be neuroprotective after stroke in 2 reports in adult rats and one in normothermic neonatal rats at higher doses (Wang et al., 2000; Kajta et al., 2009; Fu et al., 2013) , which were toxic when combined with hypothermia in our model, perhaps due to hypercalcemia demonstrated in adult rats (Wang et al., 2000) . Thus, we speculate that redox support with NAC and hypothermia permitted the effective dose of 1,25(OH) 2 D to be decreased, abrogating the well-described adverse effect of hypercalcemia, while still conferring neuroprotection to a vulnerable group of male rats.
Among HI-injured rats in our studies, only HNAC þ VitD animals continued to improve their sensorimotor adaptation, motor sequence learning and anxiety after severe HI. Essentially, HNAC þ VitD animals learned new motor skills during repetitive testing, while HNAC and HYPO animals did not, suggesting that the addition of 1,25(OH)2D results in new protective mechanisms in the prolonged recovery period after HI. As visuo-spatial learning, memory and state regulation are critical for school success, our results indicate the novel combination may also improve higherorder executive functioning as well as refractory motor outcomes in neonates with severe HIE.
Like hypothermia treatment, 1,25(OH) 2 D may improve outcomes through multiple different mechanisms of action. 1,25(OH) 2 D is a potent neurosteroid, and its nuclear receptors are widely expressed in neural cells in a similar distribution in both rodent and human brain (Eyles et al., 2005) . The circulating prohormone, 25(OH)D, serves as the source for intracrine conversion in neurons and glial cells to the active hormone, 1,25(OH) 2 D, which regulates transcriptional responses related to redox state, growth factor production and immune function, in neurons and microglia in an autocrine and paracrine fashion, all of which may influence recovery from HI injury (Fernandes de Abreu et al., 2009) .
We initially postulated that 1,25(OH) 2 D primarily acted on immune regulators, chemokines and cytokines, as males have greater immune activation than female neonatal mice by 3 days after mild to moderate HI (Mirza et al., 2015) and post-ischemic neuroinflammation contributes greatly to secondary neural damage (Liu and McCullough, 2013 ). Although we found some evidence to support a role of 1,25(OH) 2 D in immune transition in the subacute phase, and vitamin D degradation correlated strongly with neuroinflammation, we did not identify overwhelming evidence in multiple cytokine or chemokine factors that we postulated. These results might be different in the first days after HI, as Mirza has shown increased serum IL-1b, increased peripheral monocyte and lymphocyte infiltration into CNS, and increased microglial activation in male versus female HI mice at 3 days (but not 1 day) after HI; males also had more cerebral atrophy at 30 days (Mirza et al., 2015) . In our previous work in this severe HI model, NAC with hypothermia neutralized sex differences in CNS iNOS, nNOS, MMP9, CXCL1/ 2, and IL-6 at 24 h (Nie et al., 2016) , and these are not likely to be causal in the male-dependent benefit of 1,25(OH) 2 D that we observed. Thus, contrary to our initial proposed mechanism of action for 1,25(OH) 2 D, we did not see dramatic differences in the immune mediators either in male sex or in the 1,25(OH) 2 D treatment group at 11 days post HI.
Evidence in the literature supports other potential 1,25(OH) 2 D neuroprotective mechanisms that we did not investigate, particularly involving GSH repletion by the combination of NAC and 1,25(OH) 2 D. 1,25(OH) 2 D is known to increase reduced glutathione (GSH) and decrease lipid peroxides by inducing two rate-limiting enzymes in GSH synthesis, glutamate-cysteine ligase (GCL) and glutathione reductase (GSH-R), as well as glutathione peroxidase (GPx), which oxidizes GSH to GSSG, as it reduces lipid and superoxide radicals (Jain et al., 2014; Jain and Micinski, 2013; Paintlia et al., 2015; Garcion et al., 1999; George et al., 2012) . In further support of this potential mechanism of action, other investigators have demonstrated increased and prolonged oxidative stress with greater mitochondrial dysfunction, and more oxidative damage in the cortex and hippocampus in male compared with female neonatal HI rats (Demarest et al., 2016) . Female neonatal sham rats had 30% more CNS glutathione than males, and increased glutathione peroxidase, which was impaired after HI in males (Demarest et al., 2016) . Our earlier work is also consistent with persistent oxidative stress in males: NAC decreases 24 h infarct volumes in female, but not male, neonatal rats after severe HI (Nie et al., 2016) . Males have higher CNS iNOS expression than females and only improve with prolonged NAC treatment (Nie et al., 2016) .
Persistent oxidative stress may be pivotal in males as GSH depletion potentiates glutamate and nitric oxide cytotoxicity in neurons (Ibi et al., 1999) . Pretreatment with 1,25(OH) 2 D is neuroprotective in a dose dependent manner against reactive oxygen species-induced neurotoxicity in both dopaminergic and nondopaminergic neurons, but 1,25(OH) 2 D is not a direct ROS scavenger (Ibi et al., 2001) . Since NAC increases GSH by scavenging ROS and providing cysteine for GSH synthesis, and 1,25(OH) 2 D induces both enzymes responsible for GSH synthesis, the two agents may work synergistically to increase GSH (Jain and Micinski, 2013; Garcion et al., 1999) , although 1,25(OH) 2 D's effect requires protein synthesis and takes more time (Ibi et al., 1999) . If the male susceptibility to mitochondrial dysfunction, increased mitochondrial reactive oxygen species and decreased glutathione after HI (Demarest et al., 2016) are the primary mechanisms leading to apoptosis inducing factor-mediated cell death and worse outcomes in males (Renolleau et al., 2008) , then we speculate that augmented and prolonged glutathione production may provide neuroprotection without the neurotoxicity seen with higher NAC dosing in this model (Nie et al., 2016) .
Addressing neuroprotection by sex is an extremely important translational goal. Mechanisms of injury and treatment effects after HI are increasingly recognized as sex specific, as is the importance of performing studies powered for sex specific effects. Along with differences in susceptibility to oxidative stress (Demarest et al., 2016) , different apoptotic pathways (Renolleau et al., 2008) , and differences in immune activation (Mirza et al., 2015) , increased CNS vitamin D degradation, persistent hippocampal dysregulation, and lower serum vitamin D in males can now be added to other sexespecific mechanisms that may impact outcome following brain injury. As males have worse outcomes after neonatal brain injury in both preclinical and clinical studies (Smith et al., 2014; Cohen and Stonestreet, 2014) , the positive effect of active 1,25(OH) 2 D treatment on male rats may also have important clinical translational significance. In summary, these results indicate that 1,25(OH)2D treatment is an effective adjunct therapy with NAC and hypothermia by replenishing active 1,25(OH)2D, which may be particularly important in recovery after HI in male rats.
Our translational investigations have several limitations. First, in order to minimize unnecessary animal use and lack of clinical translational utility, we did not include normothermia as a control group. Hypothermia is clinical standard of care for infants with moderate to severe HIE, and normothermia would not be used clinically in these infants. Secondly, although we are targeting a more severe HI group of hypothermic treatment failures, a lack of response to hypothermia cannot be predicted prospectively, and NAC þ VitD would not be used clinically without hypothermia. Thirdly, to determine if NAC þ VitD has efficacy in the few infants who would not undergo hypothermic treatment (milder HI presenting outside of the 6 h hypothermia therapeutic window), thorough studies of dose interval and response under normothermic HI would be necessary, which were outside the scope of these studies. As we have shown in other translational work (Nie et al., 2016; Khan et al., 2004) (Kajta et al., 2009) , perhaps due to dose-limiting hypercalcemia seen in adult HI rats receiving 1 mg/kg (Wang et al., 2000) . Our early dose response studies showed much less 1,25(OH) 2 D was needed in combination with NAC and hypothermia for preservation of hemispheric volumes. Therefore, we tested a single 1,25(OH) 2 D dose in combination with NAC and hypothermia, which we felt was more likely to have a favorable safety profile for clinical translational studies.
Other limitations include the lack of histology and inadequate tissue remaining to test other hypotheses for 1,25(OH)2D mechanism of action. Little intact tissue is present in the ipsilateral hemisphere in our severe HI model in hypothermia treated animals, which limits the usefulness of histology that is so revealing in milder models. With such severe atrophy as in our samples, other investigators show that gliosis and extreme neural loss is reflected in and strongly correlated with the total hemispheric and hippocampal volume loss (Ten et al., 2004; Tang et al., 2016) .
Our study is one of the first studies to assess circulating vitamin D deficiency in severe neonatal HI, as well as vitamin D catabolism via CYP24A1. Males in particular benefitted from active 1,25(OH) 2 D treatment in long-term sensorimotor, visuospatial memory studies, perhaps due to greater systemic vitamin D deficiency, greater degradation of vitamin D in the CNS and dysregulated vitamin D metabolism in the male hippocampus compared with females.
Conclusions
A two-week treatment of NAC and 1,25(OH) 2 D improved strength, paw preference, anxiety, sensorimotor skills, as well as visuospatial learning and working memory over hypothermia alone in a neonatal rat severe HI model. Serum vitamin D deficiency and increased catabolism of both active and prohormone vitamin D in the hippocampus at 11 days after HI indicate prolonged vitamin D dysregulation, particularly in males. The combination of NAC and 1,25(OH) 2 D may augment hypothermia-induced neuroprotection and preservation of function via novel mechanisms, as our studies indicate only modest impact on immunoregulatory pathways in the second week after HI. These studies add significant impetus to further translational research of this novel combination of treatments.
